- Question from NinaV: When would you anticipate pertuzumab and TDM1 might become available?
- Answers - Eric Winer, M.D. I personally had hoped that TDM1 (chemical name: ado-trastuzumab emtansine) might be available in the next few months, but that will not be the case based on decisions by the FDA. I hope it will be available in the next 1-2 years, but cannot say for certain. In terms of pertuzumab (brand name: Omnitarg), we are waiting for definitive trials. I think it is conceivable that pertuzumab could also be available in the next 1-2 years. There are a limited number of trials with TDM1 and some patients can receive the drug as part of a clinical trial.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.